Horizon Europe ^Investors

Horizon Europe is an European Union's research & innovation framework programme for 2021-2027. Located in The Hague, Zuid-Holland, The Netherlands, Horizon Europe operates primarily in the European Union (EU), Europe, Middle East, and Africa (EMEA) regions. Founded in 1958, Horizon Europe has made investments in the pharmaceutical and biomed sectors, with notable investments in Achilles Therapeutics and Renalytix AI. These investments highlight Horizon Europe's influence and support in advancing breakthrough technologies and medical advancements in the fields of biotech, pharma, and Biomed.